The theme of this hybrid meeting is Controversies and uncertainties – Unanswered questions in myeloma. The Michael Morley Lecture – Bispecific Abs and CAR-T: sequencing toxicities and practicalities – will be delivered by Professor Niels van der Donk, Amsterdam University Medical Centre.

TOPICS COVERED

Presentations from guest speakers with sessions -

What now for ASCT in myeloma?, Debate: Role of 1st ASCT - do we still need it at all?, Michael Morley Lecture, Debate: Early Treatment vs 'monitoring' in biochemical relapse, Debate: Should we treat high risk smouldering myeloma?

WHO SHOULD ATTEND?

Suitable for Consultants, Trainees, Nurses, Scientists, Pharmacists and anyone working in the field of myeloma.

SPEAKERS

• Dr Sally Moore
• Dr Andrew Charlton
• Dr Jonathan Sive
• Dr Rakesh Popat
• Dr Kirsty Cuthill
• Dr Ceri Bygrave
• Professor Guy Pratt
• Dr Matthew Jenner
• Prof Niels van der Donk
• Dr Charlotte Pawlyn
• Dr Emma Searle
• Dr Dean Smith
• Dr Jaimal Kothari

For more information, please contact: [email protected]